Tissue Fixation Devices Market Report 2025

This tissue fixation devices market report delivers an in-depth analysis of the market’s key characteristics, including size, growth potential, and segmentation. It provides a detailed breakdown of the market across major regions and leading countries, highlighting historical data and future growth projections. The report also examines the competitive landscape, market share insights, emerging trends, and strategic developments shaping the market.

The tissue fixation devices market size has grown strongly in recent years. It will grow from $15.67 billion in 2024 to $16.58 billion in 2025 at a compound annual growth rate (CAGR) of 5.8%. The growth in the historic period can be attributed to advancements in surgical techniques, a rising incidence of orthopedic disorders, an aging population, the development of advanced materials and designs for tissue fixation devices, and rising participation in sports and recreational activities.

The tissue fixation devices market size is expected to see strong growth in the next few years. It will grow to $20.57 billion in 2029 at a compound annual growth rate (CAGR) of 5.5%. The growth in the forecast period can be attributed to growth in ambulatory surgical centers, the emergence of biodegradable devices, increasing healthcare expenditure, rising awareness and screening programs, and 3D printing and smart materials in tissue fixation devices. Major trends in the forecast period include the adoption of biodegradable fixation devices, technological advancements, minimally invasive surgery (MIS) techniques, smart implants, and IoT (internet of things) integration, and a focus on regenerative medicine.

The growth of the tissue fixation devices market is expected to be driven by the increasing prevalence of chronic diseases. The rise in chronic conditions can be attributed to factors such as aging populations, sedentary lifestyles, rising obesity rates, and enhanced diagnostic capabilities. Tissue fixation devices are crucial in the management of chronic diseases as they stabilize and support tissues during surgical interventions, thereby promoting effective healing and improving patient outcomes. For instance, in February 2024, the National Center for Health Statistics, a US-based health statistics agency, reported that the age-adjusted prevalence of diagnosed arthritis among adults aged 18 and older was 18.9% in 2022. Women were more affected, with a prevalence of 21.5% compared to 16.1% in men. Arthritis prevalence also increased with age, starting at 3.6% for adults aged 18-34 and rising to 53.9% for those aged 75 and older. This rising prevalence of chronic diseases is driving the growth of the tissue fixation devices market.

Key players in the tissue fixation devices market are concentrating on developing advanced tissue stabilization systems to enhance treatment outcomes and patient care. Tissue stabilization systems are medical devices designed to support and secure tissues during repair or surgical procedures, thus improving stability and facilitating healing. For example, in May 2022, Paragon 28 Inc., a US-based medical device company, introduced the TenoTac 2 Soft Tissue Fixation System. This system is designed to enhance the treatment of hammertoe and other soft tissue repair procedures by offering improved soft tissue capture for better stabilization and correction of contractures in the lesser toes. It also features streamlined tensioning capabilities, which facilitate the precise application of tension to soft tissues during surgery.

In July 2024, Stryker Corporation, a US-based medical technology company, acquired Artelon Inc. for an undisclosed amount. This acquisition is aimed at incorporating innovative soft tissue fixation technologies into Stryker’s product portfolio, thereby strengthening its competitive position and expanding its offerings in the foot, ankle, and sports medicine segments. Artelon Inc., a US-based manufacturer, specializes in soft tissue fixation products for foot, ankle, and sports medicine procedures.

Major companies operating in the tissue fixation devices market are Medtronic plc, Stryker Corporation, Boston Scientific Corporation, B. Braun Group, Zimmer Biomet Holdings Inc., Smith & Nephew plc, Ethicon Inc., Cook Medical Incorporated, Arthrex Inc., Integra LifeSciences Holdings Corporation, In2Bones Global Inc., Conmed Corporation, Wright Medical Group N.V., Orthofix Medical Inc., LimaCorporate S.p.A., Exactech Inc., RTI Surgical Holdings Inc., Medartis AG, Aap Implantate AG, Promedics Orthopaedic Ltd.

North America was the largest region in the tissue fixation devices market in 2023. The regions covered in the tissue fixation devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the tissue fixation devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Tissue fixation devices are medical instruments or implants used to stabilize, secure, or hold tissue in place during surgical procedures. Their purpose is to facilitate proper healing by maintaining the tissue in the correct position, preventing movement, and ensuring that the tissue heals as intended. These devices are commonly used in surgeries involving bones, muscles, tendons, and soft tissues.

The main types of tissue fixation devices include sutures and suture anchors, interference screws, plates and pins, buttons, arrows, darts, and other similar devices. Sutures and suture anchors are employed to secure tissues together during surgeries, aiding in healing and stability. Tissue fixation devices are applied in various areas such as routine histology, immunohistochemistry, in situ hybridization, electron microscopy, and molecular diagnostics. They are used by a range of end users, including hospitals, diagnostic laboratories, research institutes, biomedical companies, and forensic laboratories.

The tissue fixation devices market research report is one of a series of new reports that provides tissue fixation devices market statistics, including tissue fixation devices industry global market size, regional shares, competitors with a tissue fixation devices market share, detailed tissue fixation devices market segments, market trends and opportunities, and any further data you may need to thrive in the tissue fixation devices industry. This tissue fixation devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The tissue fixation devices market consists of sales of bone grafts and substitutes, endoscopic clips, tissue adhesives, and staples. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 3-5 business days.